Healthcare provider profile · identity verified

Gordon Gold

Internal Medicine · CRANBERRY TWP, PA · NPI 1336112960

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	910	261
Amlodipine Besylate	Amlodipine Besylate	485	145
Levothyroxine Sodium	Levothyroxine Sodium	429	119
Losartan Potassium	Losartan Potassium	381	111
Lisinopril	Lisinopril	367	117
Metformin Hcl Er	Metformin Hcl	312	109
Rosuvastatin Calcium	Rosuvastatin Calcium	274	90
Trazodone Hcl	Trazodone Hcl	241	68
Metoprolol Succinate	Metoprolol Succinate	238	60
Pravastatin Sodium	Pravastatin Sodium	192	52
Omeprazole	Omeprazole	186	62
Hydrochlorothiazide	Hydrochlorothiazide	178	54
Pantoprazole Sodium	Pantoprazole Sodium	170	61
Simvastatin	Simvastatin	160	50
Tamsulosin Hcl	Tamsulosin Hcl	155	45
Gabapentin	Gabapentin	153	44
Metoprolol Tartrate	Metoprolol Tartrate	145	45
Fluticasone Propionate	Fluticasone Propionate	138	45
Methylprednisolone	Methylprednisolone	133	110
Ozempic	Semaglutide	129	18
Duloxetine Hcl	Duloxetine Hcl	119	38
Sertraline Hcl	Sertraline Hcl	117	38
Escitalopram Oxalate	Escitalopram Oxalate	112	33
Alprazolam	Alprazolam	111	43
Bupropion Xl	Bupropion Hcl	108	30
Jardiance	Empagliflozin	108	29
Eliquis	Apixaban	107	25
Carvedilol	Carvedilol	100	31
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	98	87
Montelukast Sodium	Montelukast Sodium	90	24
Synthroid	Levothyroxine Sodium	90	28
Citalopram Hbr	Citalopram Hydrobromide	89	24
Metformin Hcl	Metformin Hcl	89	29
Atenolol	Atenolol	88	29
Albuterol Sulfate Hfa	Albuterol Sulfate	84	27
Allopurinol	Allopurinol	84	25
Doxycycline Hyclate	Doxycycline Hyclate	83	68
Famotidine	Famotidine	83	28
Azithromycin	Azithromycin	77	67
Furosemide	Furosemide	75	23
Clonidine Hcl	Clonidine Hcl	71	18
Potassium Chloride	Potassium Chloride	70	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	66	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	66	19
Warfarin Sodium	Warfarin Sodium	63	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	60	19
Irbesartan	Irbesartan	59	19
Amoxicillin	Amoxicillin	54	29
Finasteride	Finasteride	53	17
Meloxicam	Meloxicam	52	17
Xarelto	Rivaroxaban	47	13
Lorazepam	Lorazepam	46	suppressed
Prednisone	Prednisone	46	36
Valsartan	Valsartan	46	14
Venlafaxine Hcl Er	Venlafaxine Hcl	46	14
Clopidogrel	Clopidogrel Bisulfate	44	14
Fluoxetine Hcl	Fluoxetine Hcl	44	12
Oxybutynin Chloride Er	Oxybutynin Chloride	44	suppressed
Ezetimibe	Ezetimibe	43	15
Clonazepam	Clonazepam	40	suppressed
Valacyclovir	Valacyclovir Hcl	40	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	12
Breo Ellipta	Fluticasone/Vilanterol	37	suppressed
Ibuprofen	Ibuprofen	36	11
Tradjenta	Linagliptin	36	suppressed
Alendronate Sodium	Alendronate Sodium	34	11
Oxycodone Hcl	Oxycodone Hcl	34	15
Mirtazapine	Mirtazapine	33	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	33	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	33	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Spironolactone	Spironolactone	31	12
Paxlovid	Nirmatrelvir/Ritonavir	30	30
Pregabalin	Pregabalin	29	suppressed
Ketoconazole	Ketoconazole	28	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Colchicine	Colchicine	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	11
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Cefuroxime	Cefuroxime Axetil	25	18
Trulicity	Dulaglutide	25	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Celecoxib	Celecoxib	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Baclofen	Baclofen	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	20
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Topiramate	Topiramate	21	suppressed
Naproxen	Naproxen	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Felodipine Er	Felodipine	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	19	suppressed
Klor-Con M20	Potassium Chloride	19	suppressed
Glimepiride	Glimepiride	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Mupirocin	Mupirocin	17	11
Linzess	Linaclotide	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	13
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Tramadol Hcl Er	Tramadol Hcl	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error